Abstract
Background/purpose
Abdominal lymphatic malformations (LM) are a rare subset of vascular anomaly caused
by abnormal development of the lymphatic system. They are classified as macrocystic,
microcystic or combination macrocystic and microcystic. Surgical resection, percutaneous
sclerotherapy, and medical therapy are all employed to treat these complex and often
symptomatic lesions. No standardized treatment algorithm exists currently. The purpose
of this study was to establish a multidisciplinary treatment approach to abdominal
LMs.
Methods
A retrospective observational study was conducted from 2013 to 2019 on patients with
abdominal LMs at a single tertiary children's hospital vascular anomalies center.
Demographics, imaging, and treatment modality were recorded. Clinical and/or radiographic
response to the primary treatment modality as well as complications was the outcomes
measured.
Results
Nineteen patients (12 macrocystic, 5 microcystic and 2 combined) were identified,
with a median age at diagnosis of 2.2 years (range 0.1–20.8 years). Sclerotherapy
was the most common primary treatment, followed by surgical resection and sirolimus.
No difference in clinical response (p = 0.58) or complications (p = 0.31) was observed
based on primary treatment or subtypes.
Conclusions
Based on our institutional experience, we propose an LM subtype-based treatment algorithm
for abdominal LMs. It employs a multidisciplinary approach, and results in satisfactory
patient outcomes with minimal complications.
Level of evidence
Level III, retrospective comparative study.
Abbreviations:
LM (lymphatic malformation), ISSVA (International Society for the Study of Vascular Anomalies)Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- ISSVA classification of vascular anomalies ©2018 International Society for the Study of Vascular Anomalies.(Available at)issva.org/classificationDate accessed: December 6, 2019
- Vascular anomalies in pediatrics.Surg Clin North Am. 2012 Jun; 92: 769-800https://doi.org/10.1016/j.suc.2012.03.016
- Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations.JAMA Otolaryngol Head Neck Surg. 2014 Jan; 140: 41-45https://doi.org/10.1001/jamaoto.2013.5849
- Sclerotherapy of abdominal lymphatic malformations with doxycycline.J Vasc Interv Radiol. 2011 Oct; 22: 1431-1435https://doi.org/10.1016/j.jvir.2011.06.021
- Lymphatic malformation: risk of progression during childhood and adolescence.J Craniofac Surg. 2012 Jan; 23: 149-152https://doi.org/10.1097/SCS.0b013e3182413ea8
- Management of visceral vascular anomalies.Semin Pediatr Surg. 2014 Aug; 23: 216-220https://doi.org/10.1053/j.sempedsurg.2014.07.003
- Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities.J Pediatr Surg. 2008 Jan; 43 (discussion 140): 136-139
- An 8-year population description from a national treatment centre on lymphatic malformations.J Plast Surg Hand Surg. 2017 Aug; 51: 280-285https://doi.org/10.1080/2000656X.2016.1254092
- Percutaneous sclerotherapy of lymphatic malformations with doxycycline.Lymphat Res Biol. 2008; 6: 209-216https://doi.org/10.1089/lrb.2008.1004
- Sclerotherapy for intra-abdominal lymphatic malformations in children.Eur J Pediatr Surg. 2014 Aug; 24: 317-321https://doi.org/10.1055/s-0033-1349058
- Symptom resolution and volumetric reduction of abdominal lymphatic malformations with sclerotherapy.J Surg Res. 2019 Jan; 233: 256-261https://doi.org/10.1016/j.jss.2018.07.031
- Late sequelae and long-term outcomes of vascular anomalies.Semin Pediatr Surg. 2017 Oct; 26: 317-321https://doi.org/10.1053/j.sempedsurg.2017.09.007
- An approach to the management of common vascular malformations of the trunk.J Craniofac Surg. 2006 Jul; 17: 761-766
- Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies.Pediatrics. 2016; 137e20153257https://doi.org/10.1542/peds.2015-3257
Article info
Publication history
Published online: October 18, 2020
Accepted:
October 10,
2020
Received in revised form:
September 18,
2020
Received:
June 24,
2020
Footnotes
☆Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Identification
Copyright
© 2020 Published by Elsevier Inc.